Drum roll… In Vivo’s 2026 Rising Leaders were announced this week and included not one, not two, but five Optimum clients. A huge congratulations to Colleen Acosta of Freya Biosciences, Diana Čekatauskaitė of Lonza’s Synaffix, Reuben Dawkins of Link Biologics, Michelle Morrow of Nucleome Therapeutics, and Javier Nunez-Vicandi of Sofinnova Partners. This list recognises not […]
If a good rule of thumb for a conference is how full the hall is at the end of the day compared to the start, then the 21st Anglonordic Life Science Conference held last Thursday, attended by well over 300 people, was a resounding success. Maybe it was still full because attendees were keen to […]
Strategic investment from the Bill & Melinda Gates Foundation with additional investment from EIFO brings the total to $11.8 million The new investment extends Series A investment to about $50 million Funds will be used to expand Freya’s DYSCOVERTM platform to identify and develop microbial immunotherapies to treat bacterial vaginosis and prevent pre-term birth COPENHAGEN, Denmark and BOSTON, Nov. 19, 2024 /PRNewswire/ — Freya […]
